CA1305136C - Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparation - Google Patents
Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparationInfo
- Publication number
- CA1305136C CA1305136C CA000538880A CA538880A CA1305136C CA 1305136 C CA1305136 C CA 1305136C CA 000538880 A CA000538880 A CA 000538880A CA 538880 A CA538880 A CA 538880A CA 1305136 C CA1305136 C CA 1305136C
- Authority
- CA
- Canada
- Prior art keywords
- trans
- retinoic acid
- coa
- cis
- retinoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical class OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 title claims abstract description 24
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 title claims abstract description 8
- 229960005280 isotretinoin Drugs 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 15
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 15
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 claims abstract description 7
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005516 coenzyme A Substances 0.000 claims abstract description 5
- 229940093530 coenzyme a Drugs 0.000 claims abstract description 5
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229960001727 tretinoin Drugs 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 101100170172 Caenorhabditis elegans del-10 gene Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000009786 epithelial differentiation Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- KCWYOFZQRFCIIE-UHFFFAOYSA-N ethylsilane Chemical compound CC[SiH3] KCWYOFZQRFCIIE-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- HVFSJXUIRWUHRG-UHFFFAOYSA-N oic acid Natural products C1CC2C3CC=C4CC(OC5C(C(O)C(O)C(CO)O5)O)CC(O)C4(C)C3CCC2(C)C1C(C)C(O)CC(C)=C(C)C(=O)OC1OC(COC(C)=O)C(O)C(O)C1OC(C(C1O)O)OC(COC(C)=O)C1OC1OC(CO)C(O)C(O)C1O HVFSJXUIRWUHRG-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000538880A CA1305136C (fr) | 1987-06-04 | 1987-06-04 | Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000538880A CA1305136C (fr) | 1987-06-04 | 1987-06-04 | Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1305136C true CA1305136C (fr) | 1992-07-14 |
Family
ID=4135826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000538880A Expired - Lifetime CA1305136C (fr) | 1987-06-04 | 1987-06-04 | Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparation |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1305136C (fr) |
-
1987
- 1987-06-04 CA CA000538880A patent/CA1305136C/fr not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07506192A (ja) | タンパク質構造決定のための組成物類および方法類 | |
US4338251A (en) | Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same | |
EP0271552B1 (fr) | Dérivés de l'acide (trans)-rétinoique et de l'acide (cis)-13-rétinoique et procédés de preparation | |
CA1305136C (fr) | Derives de l'acide retinoique entierement trans et 13-cis, et methodes pour leur preparation | |
FR2543144A1 (fr) | Procede d'isolation de saponines de soya | |
US4644067A (en) | Process for the extraction of amino acids from an aqueous phase | |
CA1246062A (fr) | Derives d'anthracycline, leur preparation et leur emploi a titre d'agents cytostatiques | |
Cook et al. | Metabolism of “wild” yeasts I. The chemical nature of pulcherrimin | |
US5041689A (en) | Method of recovering L-quebrachitol from rubber latex serums | |
US4966965A (en) | Method for preparing all-trans retinoyl CoA | |
US4420473A (en) | Antibiotic, MF266 substance and production thereof | |
EP0382506B1 (fr) | Sels diastéréoisomères optiquement actifs de l'acide tétrahydro-2-furoique | |
Karmarkar et al. | Synthesis of p-Nitrophenyl Substituted Tetrazolium Salts Containing Iodine and Other Groups1 | |
CA1328104C (fr) | 24r-scymnol, sa preparation et son utilisation | |
EP0365210A1 (fr) | Dérivés de l'acide hydroxamique | |
EP0533115A1 (fr) | Procédé pour la production d'hydroxocobalamin | |
JP2571279B2 (ja) | シコニンの製造方法 | |
JPS639838B2 (fr) | ||
JPH06157394A (ja) | ベナスタチンc及びdの合成法 | |
JP2629375B2 (ja) | アミノ基が保護されたドーパ又はドーパ誘導体の製造法 | |
Kutner et al. | Synthesis of coenzyme A ester of retinoic acid: intermediate in vitamin A metabolism. | |
JP2971204B2 (ja) | 新規物質wk−2955およびその製造法 | |
CN116082145A (zh) | 一种具有抗氧化活性的贝特类衍生物、合成方法及其应用 | |
JP2728735B2 (ja) | 天然ゴム漿液中のl―クエブラキトールの採取方法 | |
JP3865781B2 (ja) | K−252aの精製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20020715 |